Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Uterine Cervical Dysplasia 1 Stomatitis 1 Rectal Neoplasms 1 Pain 1 Neurofibromatosis 1 1 Lung Neoplasms 1 Castration Sensitive Prostate Cancer 1 Breast Neoplasms 1 Advanced Cancers 1

Interventions

Radiotherapy 38 Carboplatin 37 pembrolizumab 36 Cisplatin 34 Paclitaxel 26 Pemetrexed 24 Docetaxel 18 Nivolumab 17 Gemcitabine 17 Bevacizumab 17 Specimen Handling 16 Magnetic Resonance Spectroscopy 16 Cyclophosphamide 15 osimertinib 14 Irinotecan 13 Etoposide 13 Radiation 12 Erlotinib Hydrochloride 12 durvalumab 11 Topotecan 10 Cetuximab 10 Radiosurgery 8 Immunoglobulin G 8 Fluorouracil 8 Everolimus 8 Disulfides 8 Celecoxib 8 fludarabine 7 Taxes 7 Ipilimumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lung Neoplasms × Curcumin × Clear all

NCT02321293 2015-09-02

CURCUMIN

Lady Davis Institute

Phase 1 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡